MedTrace Logo

Assessment of the Effectiveness of Chemotherapy Teaching: BrUOG 258

NCT01827761 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2022-02-24

No results posted yet for this study

Summary

This study will evaluate whether chemotherapy teaching sessions improves patient's knowledge, preparedness and anxiety in relation to chemotherapy. This study will also evaluate the effect of age, race, native language, education level, type of cancer and chemotherapy regimen on the oncology teaching session.

Conditions

Interventions

BEHAVIORAL

Questionnaire

After informed consent for this study is obtained, patients will be given questionnaire #1 that includes rating their knowledge of the side effects of treatment, their understanding of the treatment schedule, what do in the event of complication, how to reach the medical team and an assessment of the level of anxiety. The questionnaire will be repeated at day 1 of the first chemotherapy treatment to assess the effectiveness of the teaching session. In addition, questionnaire #3 will be administered at day 1 of cycle 2 of their first chemotherapy.

Sponsors & Collaborators

  • Rhode Island Hospital

    collaborator OTHER

  • The Miriam Hospital

    collaborator OTHER

  • Fatima Memorial Hospital

    collaborator OTHER

  • Roger Williams Medical Center

    collaborator OTHER

  • Lifespan

    collaborator OTHER

  • Brown University

    lead OTHER

Principal Investigators

  • Anthony Mega, MD · Brown University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01827761 on ClinicalTrials.gov